Fine SR et al. - The article discusses the role of non–subtype-selective and subtype-selective 1-adrenergic receptor antagonists in the clinical management of BPH. Safety and tolerability for both non–subtype-selective and subtype-selective 1-adrenergic receptor antagonists for patients with BPH are also reviewed.